Atlanta Golf Classic closes in on $1 million in charitable giving

6th annual tournament has raised $800,000 in first 5 years for TGen pancreatic cancer research

ATLANTA - Sept. 15, 2015 - Golfers and non-golfers alike will swing toward $1 million in charitable giving in the upcoming Howard Young's 6th annual Atlanta Golf Classic, slated for Sept. 29 at the spectacular Capital City Club at Crabapple in Alpharetta.

In the past 5 years, the event has raised more than $800,000 in support of pancreatic cancer research at the Phoenix-based Translational Genomics Research Institute (TGen).

All funds go to TGen's research into early detection and better treatments for pancreatic cancer, the nation's fourth leading cause of cancer-related death.

"I have now survived 13 years with this most aggressive of cancers thanks to the incredible work done at TGen and its Physician-In-Chief Dr. Daniel Von Hoff," said Howard Young, an Atlanta businessman who credits TGen and Dr. Von Hoff with saving his life.

Dr. Von Hoff, who is world renowned for his contributions to pancreatic cancer research, has led teams that were instrumental in the development of major anti-pancreatic cancer agents that have significantly improved patients' survival.

"With a little help from our friends, we could come close to reaching the $1 million mark this year," said Young, a Board Member of the TGen Foundation, and chair of its National Pancreatic Cancer Committee.

The tournament field, limited to 120 golfers, is expected to sell out, as it has in past years.

Pancreatic cancer this year will take the lives of more than 40,000 Americans, making it the nation's fourth leading cause of cancer-related death. Median survival for patients with advanced disease is less than 6 months following diagnosis, and the 5-year survival rate is less than 10 percent for all patients.

Pancreatic cancer's lethal nature stems from its propensity to rapidly spread to distant organs, especially the liver and the lungs. Survival remains low partly because no early screening test exists.

The Atlanta Golf Classic is held in association with the Scottsdale-based Seena Magowitz Foundation.

"The remarkable fundraising efforts of Howard Young, a long-time pancreatic cancer survivor, gives testament to value of the advances being made by TGen and Dr. Von Hoff," said Roger E. Magowitz, Presidentof the Seena Magowitz Foundation, which he founded in honor of his mother, Seena, whodied of pancreatic cancer in 2001.

This 6th annual tournament will be co-hosted by Howard Young, John Morley, Randy Dobbs, and Jane and Bill Young.

Registrations and donations are still being accepted, and non-golfers are invited to attend the tournament's awards luncheon. Please contact Tournament Director Liz McBeth at [email protected] or (757) 773-3622.

For more information, visit, or contact Roger E. Magowitz at [email protected] or 602-524-7636.

To learn more about TGen's work in pancreatic cancer, watch a video that includes Howard Young, his wife Becky Young, Roger E. Magowitz, Dr. Daniel Von Hoff, TGen President Dr. Jeffrey Trent, TGen Foundation President Michael Bassoff, former U.S. Vice President and TGen Foundation Board Member Dan Quayle, Arizona Diamondbacks President & CEO Derrick Hall, New York Yankees Senior Vice President & General Manager Brian Cashman, Leggett & Platt Inc. President and CEO Karl Glassman, and Mattress Firm Executive Vice President Karrie Forbes, at:

# # #

About the Seena Magowitz Foundation

The Seena Magowitz Foundation is a 501(c)(3) non-profit organization committed to advancing the awareness and eventual prevention and cure of pancreatic cancer. The Foundation is dedicated to funding top medical institutions on the leading edge of translational pancreatic cancer research committed to diagnosis, the advancement of life-extending treatment options and the ultimate goal of eradicating this deadly killer. For more information, visit:


About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, Follow TGen on Facebook, LinkedIn and Twitter @TGen.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed